IL17A and fatty liver disease: Furthermore, both hepatic steatosis and the infiltration of inflammatory cells were attenuated in mice that received Il17+/+ CD4+ T cells, as determined by histological analysis (Fig. 5H), and the levels of ALT and AST also decreased (Fig. 5I).